A suggestion to introduce the diagnosis of “diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)”
A suggestion to introduce the diagnosis of “diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)”
复制标题
建议介绍“脑桥弥漫性中线胶质瘤,H3 K27野生型(WHO IV级)”的诊断
DOI:
10.1007/s00401-018-1863-6
复制
发表时间:
2018
影响因子:
12.7
通讯作者:
C. Kramm
中科院分区:
文献类型:
--
作者:
A. V. von Bueren;M. Karremann;G. Gielen;M. Benesch;M. Fouladi;D. V. van Vuurden;S. V. van Zanten;L. Hoffman;C. Kramm
We have read with great interest the publication regarding clarification of criteria for diffuse midline glioma, H3 K27M-mutant by Louis et al.[5] and would like to contribute to the discussion the following point. It has been common sense now for nearly 20 years among pediatric neurooncologists that neuroradiologically defined diffuse intrinsic pontine gliomas (DIPG) display a very poor prognosis independent of histological grade (when biopsied). Thus, biopsies had been usually omitted until recent identification of potential drug targets for individualized therapy has led to reevaluation of this approach [8]. Nevertheless, biopsies are only performed in the (admittedly growing!) minority of DIPG patients; in the majority of cases, diagnosis is still established by typical MRI features [T1-hypo (or iso) intense and T2-hyperintense tumor involving at least 50% of the pons] together with a very short clinical history (usually< 6 months), and at least one typical brainstem symptom (cranial nerve deficits, ataxia and/or long tract signs)[1].
DOI:
--
发表时间:
2014
期刊:
影响因子:
--
作者:
Naoki Tsunekawa;Nobuaki Higashi;Tatsuro Irimura.;Kaori Denda-Nagai and Tatsuro Irimura;入村達郎;浜瀬健司;浜瀬健司
通讯作者:
浜瀬健司
影响因子:
45.3
作者:
Lassaletta, Alvaro;Scheinemann, Katrin;Bouffet, Eric
通讯作者:
Bouffet, Eric